SPY
761.10
−1.39%
QQQ
707.87
−2.77%
BTC/USD
81,396.32
−0.13%
DIA
518.00
−0.59%
GLD
381.40
−0.34%
TLT
80.06
+0.11%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Natera Inc
NTRA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$393.44
-11.35
-2.8%
Last update: Oct 16, 4:44 PM
$393.44
-11.35
-2.8%
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Natera Financials
Natera (NTRA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook
Natera stock spikes as strong oncology demand drives record test volumes and a full-year revenue outlook bump.
Vandana Singh
PRO
Natera Raises FY2026 Sales Guidance from $2.740B-$2.820B to $2.850B-$2.910B vs $2.797B Est
Natera (NASDAQ:NTRA) raises FY2026 sales outlook from $2.740 billion-$2.820 billion to $2.850 billion-$2.910 billion vs $2.797 billion estimate.
Benzinga Newsdesk
PRO
Natera Q2 EPS $(0.47) Beats $(0.51) Estimate, Sales $752.750M Beat $660.687M Estimate
Natera (NASDAQ:NTRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 36.49 percent increase over losses of $(0.74) per share from the same
Benzinga Newsdesk
PRO
Natera Raises FY2026 Sales Guidance from $2.620B-$2.700B to $2.740B-$2.820B vs $2.668B Est
Natera (NASDAQ:NTRA) raises FY2026 sales outlook from $2.620 billion-$2.700 billion to $2.740 billion-$2.820 billion vs $2.668 billion estimate.
Benzinga Newsdesk
PRO
Natera Q1 EPS $(0.60) Misses $(0.57) Estimate, Sales $696.644M Beat $617.110M Estimate
Natera (NASDAQ:NTRA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.57) by 5.26 percent. This is a 20 percent decrease over losses of $(0.50) per share from the same
Benzinga Newsdesk
Earnings Summary: Natera Q4
Benzinga Insights
